About
About
Physician Bio
Dr. Jordan Geller is a native of Los Angeles. He earned his medical degree
from the University of Southern California and completed a postdoctoral
fellowship at Cedars-Sinai Medical Center in Los Angeles as well as an
NIH fellowship in Clinical Research. He was the past Clinical Chief of
the Division of Endocrinology, Diabetes & Metabolism at Cedars-Sinai
Medical Center. Dr. Geller has lectured at national symposia and authored
publications in the field of Endocrinology in prestigous journals including
Nature, Endocrine Practice, JAMA and Endocrine Pathology.
Dr. Geller is dual board-certified in Endocrinology, Diabetes and Metabolism
and Internal Medicine and licensed in California and Florida. His private
practice caters to clients who are invested in their health and well-being.
Common conditions he manages include thyroid disorders, diabetes, prediabetes,
hormone replacement, weight management, cholesterol disorders and osteoporosis.
In addtion to Western medicine, Dr. Geller incorporates lifestyle changes
and functional medicine approaches to the care of his patients whenever possible.
Areas of Interest
Thyroid disorders, diabetes, prediabetes, hormone replacement, weight management,
cholesterol disorders and osteoporosis.
Education
Education
Medical School:
University of Southern California Keck School of Medicine, Los Angeles
Residency:
Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles
Fellowship:
Cedars-Sinai Medical Center, Los Angeles
Board Certification:
Endocrinology, Diabetes and Metabolism
Internal Medicine
Diplomat of the American Board of Internal Medicine
Diplomat of the American Board of Endocrinology, Diabetes and Metabolism
Awards
American Thyroid Association Fellow’s Track Recipient, Baltimore, 2005
California Medical Assoc. Legislative Seminar grant recipient, Sacramento, 2001
Pathology Honors Program, University of Health Sciences, 1999
American Pediatric Society Research Fellowship 1998
Rutger’s University Fellowship Advanced School of Alcohol and Drug Studies, 1998
Leichtling Oncology Research Award (deferred), 1998
Illinois Academy of Family Physicians Externship, 1998
Summer Research Fellow, Univ. Health Sciences, 1997
Cum Laude Honors, Loyola Marymount University, 1993
Outstanding Graduate in Department of Sociology, Loyola Marymount Univ 2003
Presenter, Santa Clara University Sociology Research Conference, 1993, 1994
Dean’s List, Santa Monica College, 1989
Research & Publications
Research & Publications
Liu NA, Sacks W and Geller JL, Geller Epocrates Osteoporosis Curriculum 2010;
Epocrates, Inc.
Geller JL, Adams JS. Vitamin D Therapy. Current Osteoporosis Reports 2008
Cooper OB, Geller JL and Melmed S. Ovarian Hyperstimulation Syndrome caused
by an FSH-Secreting Pituitary Adenoma. Nat Clin Pract Endocrinol Metab. Feb 12,
2008
Geller JL, Hu B, Reed S, Mirocha J and Adams JS. Repair of Vitamin D Insufficiency
Increases Bone Mass in Bisphosphonate-Treated Patients. Endo Prac. 2008; 14:3
Geller JL Vitamin D: The Sunshine Hormone. Food Technology, June 2007
Geller JL, Adams, JS. Proton Pump Inhibitor Therapy and Hip Fracture Risk. JAMA.
2007; 297:1429
Geller JL, Azarmindokht K, Kelly MH, et al. Clinical Vignette: Cinacalcet in the
Management of Tumor-Induced Osteomalacia. J Bone Min Res. 2007; Mar 12
Geller JL The Way I see it: Healthcare Reform Begins with Patient. Medical
Economics. Dec 15, 2006
Karakelides H, Geller JL, Schroeter AL, Chen H, Behn PS, Adams JA, Hewison M,
Wermers RA. Vitamin D-mediated hypercalcemia in slack skin disease: further
evidence for extra-renal expression of 25-hydroxyvitamin D-1α-hydroxylase in
granulomatous disorders. J Bone Min Res. 2006 Sep; 1496-9
Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented
Adrenocrotical Carcinoma:case report and review. Endocr Pathol. 2006;
17: 297-304.
Geller JL, Braunstein GB. Dermatological Manifestations of Hypopituitarism. Clinics
in Dermatology. 2006; 42:266-275.
Geller JL. Borrowing Against the Bones: The Price of Eucalcemia. Nutrition and the
M.D. 2006; 32:5
Geller JL, Adams JS. Statins and Fracture: All Variables Accounted For?
Archives of
Internal Medicine 2006; 166:1041
Geller JL, Arteaga V, Fan X, Yu J. A Symptomatic Prolactinoma Co-existing within a
Rathke’s Cleft Cyst Invading Bone: Case Report and Review. The Endocrinologist
2006;91-94.
Publications Continued
Geller, JL, Mertens, RB and Weiss LM. Adrenocortical Carcinoma: Many Questions
Remain Unanswered. The Endocrinologist, 2005; 15: 309-312.
Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, Hu B, Lin
YC, Keenan G, Price J, Landers CJ, Targan SR. Treatment with Infliximab is
Associated With Increased Markers of Bone Formation in Patients With Crohn's
Disease. Journal of Clinical Gastroenterology, 2006; 40:55-63.
Geller JL, Hackner D. Prolonged Refractory Streptococcal Toxic Shock Syndrome
Complicoemboli: Case Report and Review. Annals of Hematology. 2005 Apr 7
Bhushan V, Pall V, Le T, Yen YM, Geller JL, Gupta S. Clinical Science
Color Atlas.
Blackwell, 2002
Abstracts
Geller JL, Reed, S, Mirocha J, Adams JS. Vitamin D Insufficiency and
Unresponsiveness to Bisphosphonates. Cleveland Clinic Bone Innovation Summit,
May 5, 2006.
JL. Geller, C. Cutler, M. H. Kelly, J. S. Adams, M. T. Collins. Cinacalcet
Is Associated
with Decreased Serum FGF-23 and Improved Phosphorous Homeostasis in
Patients with Tumor-Induced Osteomalacia. The 27th Annual Meeting of the
American Society for Bone and Mineral Research, Nashville, Tennessee, 2005.
Wermers RA, Karakelides H, Adams JS, Chen H, Geller JL, Hewison M. Vitamin
D-Mediated Hypercalcemia in Granulomatous Slack Skin Disease: Evidence for the
Extra-renal 1-Hydroxylation of 25-hydroxvitamin D in Involved Skin Granulomata.
Endocrine Society 87th Annual Meeting, San Diego, 2005
Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented
Adrenocortical Carcinoma. Endocrine Society 87th Annual Meeting, San Diego,
2005
Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, et al.
Treatment with Infliximab is Associated With Increased Markers of Bone Formation
in Patients With Crohn's Disease. American Society for Bone and Mineral Research,
26th Annual Meeting, Seattle, WA, 2004